BERKELEY, Calif. , Dec. 6, 2024 /PRNewswire/ -- Bamboo Technology , a mental health technology innovation company, is announcing its participation in Batch 19 of the prestigious UC Berkeley Skydeck IPP Program for startup acceleration. The company's HereHear AI therapist solution will be the key focus of the program, driven by the vision of revolutionizing mental health with AI-powered virtual solutions. To learn more about HereHear, please visit: https://www.youtube.com/watch?v=ngU32WgiWf4 "HereHear is here in the US, and I am truly grateful to the Berkeley Skydeck IPP Program for recognizing its potential," noted Lynia Huang , Bamboo Technology's CEO. "As important as mental health has become in recent years, there is a shortage of mental health providers and access to support is low — and HereHear is paving the way for AI to bridge that gap as a first line of defense." A growing case for incorporating AI into mental healthcare With data showing that the US is in a mental health crisis, the CDC recently noted a dire need for public health initiatives that create environments centered around mental health. Specific to the workplace, the Society for Human Resource Management's Employee Mental Health in 2024 Research Series found that 44% of US employees feel burned out at work. The combination of a shortage of mental health providers in the US with the flourishing capabilities of AI builds a strong case for the technology to be deployed in the form of human-guided mental health solutions. HereHear's YangYang: A personalized 3D virtual therapist As organizations seek out ways to empower team members to take better care of their mental health, AI is increasingly emerging as a solution for on-demand, personalized support. Offering a more engaging interaction than chatbots, HereHear's 3D virtual therapist YangYang was launched in January 2024 and offers: YangYang has already been implemented in several therapy clinics and has helped 70% of users improve stress and depression levels by 25% within 3 months. Taking the form of a sheep further distinguishes her — this functions both to provide a 'cute' aspect lending to the warm, healing emotional support she provides, while also helping users who are struggling emotionally to keep in perspective that their interactions are ultimately not with a human. Bringing success in Taiwan to the US market Bamboo Technology's acceptance into the Berkeley Skydeck IPP Program is a major accomplishment as the platform seeks to enter the US market. Batch 19 has only 117 startups out of around 2300 applications, and the program will support HereHear to develop, pilot and launch, as well as to pitch for funding. The company aims to target the app in the human resources space—as a tool for companies to offer staff for on-demand, privacy-first mental health support. Back in Taiwan , the app already has hospitals, mental health clinics, universities, publicly listed companies, and government agencies that use it, similarly spurred by a shortage of mental health workers. About Bamboo Technology Established in November 2018 , the Taipei -based Bamboo Technology is a mental health technology innovation company that focuses on improving public mental health with voice emotion analysis technology. It embraces a belief that a universal, objective, and scientific mental health system can effectively solve the problem of deteriorating mental health in today's society — a core tenet upheld by its many psychologists; social workers; and information management, AI and big data experts. View original content to download multimedia: https://www.prnewswire.com/news-releases/bamboo-technologys-herehear-virtual-ai-therapist-joins-berkeley-skydeck-ipp-program-302325187.html SOURCE BAMBOO TECHNOLOGY LTD.Bamboo Technology's HereHear Virtual AI Therapist Joins Berkeley Skydeck IPP ProgramANDOVER, Mass. , Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the appointment of Mr. Gerardo Hernandez as the Company's Chief Financial Officer, effective December 2, 2024 . In this role, Mr. Hernandez joins the TransMedics executive leadership team, succeeding Mr. Stephen Gordon . To enable a smooth transition, Mr. Gordon will remain a non-executive employee of the Company until March 31, 2025 , before serving as a non-employee senior advisor to the Company focusing on national transplant stakeholder engagement until March 31, 2026 . TransMedics also updated its 2024 financial outlook. Dr. Waleed Hassanein , Mr. Gerardo Hernandez and Mr. Stephen Gordon will attend the upcoming Piper Sandler Conference on December 3, 2024 , the TransMedics Investor & Analyst Day on December 10, 2024 , as well as the J.P. Morgan Healthcare Conference in January 2025 . Mr. Hernandez is an accomplished finance leader with over 25 years of experience across the healthcare and consumer packaged goods (CPG) sectors. He most recently served as Vice President Finance, Head of Corporate Financial Planning and Analysis at Alnylam Pharmaceuticals, a biopharmaceutical company focused on RNAi therapeutics. In this role, Mr. Hernandez led a global team as the company scaled rapidly. Prior to his role at Alnylam, Mr. Hernandez spent nearly a decade at Shire, where he rose through the organization, eventually leading corporate FP&A. During his tenure, Shire was acquired by Takeda in a $62 billion transaction, after which he was instrumental in the integration effort. Mr. Hernandez began his career at Unilever where he held several finance roles of increasing responsibility before joining Shire in 2010. Mr. Hernandez holds a Bachelor of Science degree in Finance from the University of Wisconsin , La Crosse and an MBA in Strategy and Economics from Fundação Getulio Vargas , Sao Paulo, Brazil . "Stephen has been an exceptional partner to me as a member of the TransMedics leadership team for nearly a decade. During his tenure we transitioned the Company from a clinical stage organization to a high growth, publicly traded commercial business," said Waleed Hassanein , M.D., President and Chief Executive Officer. "On behalf of the entire management team and the Board, I want to thank Stephen for his countless contributions to our business that will have lasting benefits for the Company. I am grateful for Stephen's dedication and efforts to advance our corporate strategy while delivering considerable shareholder value, and I look forward to his continued partnership to affect a smooth transition as we start our next chapter at TransMedics." "I am delighted to welcome Gerardo to the TransMedics leadership team as our new Chief Financial Officer," added Dr. Hassanein. "His proven record over two decades of leadership across FP&A functions within high-growth, complex global organizations makes him an ideal addition to our team. I am looking forward to partnering with Gerardo as we continue to deliver significant long-term corporate growth and shareholder value." "I am thrilled to join TransMedics as Chief Financial Officer," said Mr. Hernandez. "I look forward to working with the entire leadership team to expand access to the Company's unparalleled products and services in the organ transplant field while enhancing operational efficiency and delivering lasting value to both our shareholders and the patients we serve." Dr. Hassanein concluded, "As we enter the final weeks of the fourth quarter, we are also updating our financial outlook for the full year 2024. Our updated guidance reflects our continued expectation for considerable year-over-year revenue growth. We look forward to providing additional context at our upcoming Investor & Analyst Day." 2024 Financial Outlook TransMedics now expects revenue for the full year 2024 to be in the range of $428 million to $432 million, which represents 77% to 79% growth compared to the Company's prior year revenue. Piper Sandler 36th Annual Healthcare Conference Members of the TransMedics management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024 , at 4:00 p.m. Eastern Time . A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . The Company's standard investor presentation is also available through this link. TransMedics Investor & Analyst Day Details TransMedics will discuss the transition and updated financial outlook, as well as the Company's growth strategy, clinical pipeline, and operations, in greater detail at its Investor & Analyst Day in New York City on Tuesday, December 10, 2024 , at 10:00 a.m. Eastern Time . A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . Please note management will only take questions from the live audience during the question-and-answer session following formal presentations. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Forward-Looking Statements This press release contains forward-looking statements with respect to, among other things, a leadership transition and our full-year guidance. For this purpose, all statements other than statements of historical facts are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "could," "target," "predict," "seek" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Some of the key factors that could cause actual results to differ include: our ability to maintain profitability on a sustained basis; our ability to attract, train and retain key personnel; our existing and any future indebtedness, including our ability to comply with affirmative and negative covenants under our credit agreement to which we will remain subject until maturity; the fluctuation of our financial results from quarter to quarter; our need to raise additional funding and our ability to obtain it on favorable terms, or at all; our ability to use net operating losses and research and development credit carryforwards; our dependence on the success of the Organ Care System or OCS; our ability to expand access to the OCS through our National OCS Program or NOP; our ability to scale our manufacturing and sterilization capabilities to meet increasing demand for our products; the rate and degree of market acceptance of the OCS; our ability to educate patients, surgeons, transplant centers and private and public payors on the benefits offered by the OCS; our ability to improve the OCS platform and develop the next generation of the OCS products; our dependence on a limited number of customers for a significant portion of our revenue; our ability to maintain regulatory approvals or clearances for our OCS products in the United States , the European Union, and other select jurisdictions worldwide; our ability to adequately respond to the Food and Drug Administration or FDA, or other competent authorities, follow-up inquiries in a timely manner; the performance of our third-party suppliers and manufacturers; our use of third parties to transport donor organs and medical personnel for our NOP and our ability to maintain and grow our logistics capabilities to support our NOP and reduce dependence on third party transportation, including by means of attracting, training and retaining pilots, and the acquisition, maintenance or replacement of fixed-wing aircraft for our aviation transportation services or other acquisitions, joint ventures or strategic investments; our ability to maintain Federal Aviation Administration or FAA or other regulatory licenses or approvals for our aircraft transportation services; price increases of the components of our products and maintenance, parts and fuel for our aircraft; the timing or results of post-approval studies and any clinical trials for the OCS; our manufacturing, sales, marketing and clinical support capabilities and strategy; attacks against our information technology infrastructure; the economic, political and other risks associated with our foreign operations; our ability to protect, defend, maintain and enforce our intellectual property rights relating to the OCS and avoid allegations that our products infringe, misappropriate or otherwise violate the intellectual property rights of third parties; the pricing of the OCS, as well as the reimbursement coverage for the OCS in the United States and internationally; regulatory developments in the United States, European Union and other jurisdictions; the extent and success of competing products or procedures that are or may become available; our ability to service our 1.50% convertible senior notes, due 2028; the impact of any product recalls or improper use of our products; our estimates regarding revenues, expenses and needs for additional financing; and other factors that may be described in our filings with the Securities and Exchange Commission (the "SEC"). Additional information will be made available in our annual and quarterly reports and other filings that we make with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 [email protected] SOURCE TransMedics Group, Inc.
To learn more about HereHear, please visit: https://www.youtube.com/watch?v=ngU32WgiWf4 "HereHear is here in the US, and I am truly grateful to the Berkeley Skydeck IPP Program for recognizing its potential," noted Lynia Huang , Bamboo Technology's CEO. "As important as mental health has become in recent years, there is a shortage of mental health providers and access to support is low — and HereHear is paving the way for AI to bridge that gap as a first line of defense." A growing case for incorporating AI into mental healthcare With data showing that the US is in a mental health crisis, the CDC recently noted a dire need for public health initiatives that create environments centered around mental health. Specific to the workplace, the Society for Human Resource Management's Employee Mental Health in 2024 Research Series found that 44% of US employees feel burned out at work. The combination of a shortage of mental health providers in the US with the flourishing capabilities of AI builds a strong case for the technology to be deployed in the form of human-guided mental health solutions. HereHear's YangYang: A personalized 3D virtual therapist As organizations seek out ways to empower team members to take better care of their mental health, AI is increasingly emerging as a solution for on-demand, personalized support. Offering a more engaging interaction than chatbots, HereHear's 3D virtual therapist YangYang was launched in January 2024 and offers: Sophisticated vocal and emotional analysis: Aligned with professional assessment scales, it analyzes voice features in 30 seconds to detect levels of stress, depression and happiness, assessing both verbal and nonverbal cues. Broad accessibility : Multiple languages and real-time, personalized support Powered by AI and deep learning: Continuously learns from patient interaction YangYang has already been implemented in several therapy clinics and has helped 70% of users improve stress and depression levels by 25% within 3 months. Taking the form of a sheep further distinguishes her — this functions both to provide a 'cute' aspect lending to the warm, healing emotional support she provides, while also helping users who are struggling emotionally to keep in perspective that their interactions are ultimately not with a human. Bringing success in Taiwan to the US market Bamboo Technology's acceptance into the Berkeley Skydeck IPP Program is a major accomplishment as the platform seeks to enter the US market. Batch 19 has only 117 startups out of around 2300 applications, and the program will support HereHear to develop, pilot and launch, as well as to pitch for funding. The company aims to target the app in the human resources space—as a tool for companies to offer staff for on-demand, privacy-first mental health support. Back in Taiwan , the app already has hospitals, mental health clinics, universities, publicly listed companies, and government agencies that use it, similarly spurred by a shortage of mental health workers. About Bamboo Technology Established in November 2018 , the Taipei -based Bamboo Technology is a mental health technology innovation company that focuses on improving public mental health with voice emotion analysis technology. It embraces a belief that a universal, objective, and scientific mental health system can effectively solve the problem of deteriorating mental health in today's society — a core tenet upheld by its many psychologists; social workers; and information management, AI and big data experts. View original content to download multimedia: https://www.prnewswire.com/news-releases/bamboo-technologys-herehear-virtual-ai-therapist-joins-berkeley-skydeck-ipp-program-302325187.html SOURCE BAMBOO TECHNOLOGY LTD.Koi Perich, Darius Taylor post they won’t leave the GophersRich get richer: The $164 trillion inheritance windfall
DreamWorks Animation has released the trailer for The Bad Guys 2 , a sequel to the 2022 animated film. The original cast returns, and new characters are introduced. The film hits theaters in 2025. Storyline and Trailer The trailer follows the original criminal group as they adapt to life outside prison. The team must abandon their attempts at being good to take on one last heist. This mission is led by an all-female squad of characters, who bring a new dynamic to the story. Voice Cast The original cast of characters returns, including Mr. Wolf, Mr. Snake, Mr. Shark, Mr. Piranha, and Ms. Tarantula. Their voices are provided by Sam Rockwell, Marc Maron, Craig Robinson, Anthony Ramos and Awkwafina. Natasha Lyonne , Danielle Brooks and Maria Bakalova join the cast as new characters. Brooks voices the new leader, a snow leopard described as highly capable and intelligent. Her second-in-command is a boar, who is tough but kind-hearted. A sarcastic raven, with dry humor, completes the new squad. Web Development Django & PostgreSQL Mastery: Build Professional Web Applications By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Marketing Performance Marketing for eCommerce Brands By - Zafer Mukeri, Founder- Inara Marketers View Program Leadership Business Storytelling Masterclass By - Ameen Haque, Founder of Storywallahs View Program Office Productivity Microsoft Word Mastery: From Beginner to Expert By - CA Raj K Agrawal, Chartered Accountant View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance AI and Generative AI for Finance By - Hariom Tatsat, Vice President- Quantitative Analytics at Barclays View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Artificial Intelligence(AI) Java Programming with ChatGPT: Learn using Generative AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) ChatGPT Mastery from Zero to Hero: The Complete AI Course By - Metla Sudha Sekhar, IT Specialist and Developer View Program Strategy ESG and Business Sustainability Strategy By - Vipul Arora, Partner, ESG & Climate Solutions at Sattva Consulting Author I Speaker I Thought Leader View Program Web Development Intermediate Java Mastery: Method, Collections, and Beyond By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Excel Essentials to Expert: Your Complete Guide By - Study At Home, Quality Education Anytime, Anywhere View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Artificial Intelligence(AI) Tabnine AI Masterclass: Optimize Your Coding Efficiency By - Metla Sudha Sekhar, IT Specialist and Developer View Program Leadership Building Your Winning Startup Team: Key Strategies for Success By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Web Development Mastering Full Stack Development: From Frontend to Backend Excellence By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Science SQL for Data Science along with Data Analytics and Data Visualization By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Mastering C++ Fundamentals with Generative AI: A Hands-On By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Intermediate C++ Skills: Master Pointers, Structures and File Stream By - Metla Sudha Sekhar, IT Specialist and Developer View Program The sequel draws inspiration from action franchises like James Bond and Mission: Impossible. It blends animated storytelling with high-stakes action sequences. The first film, released in 2022, was a commercial success, grossing over $250 million worldwide. Release Window The Bad Guys 2 is based on Aaron Blabey's book series. The film is set to release in theaters in 2025. FAQs: What is the release date for The Bad Guys 2? The movie is scheduled for release in 2025, continuing the adventures of the original gang. Who are the new characters in The Bad Guys 2 ? The sequel introduces a snow leopard leader, a boar second-in-command, and a raven, all voiced by new cast members. (You can now subscribe to our Economic Times WhatsApp channel )Cohere CEO Aidan Gomez on what to expect from ‘AI 2.0’
BEREA, Ohio (AP) — Myles Garrett didn't know he had joined a prestigious list of defensive stars last week until one of his biggest fans pointed it out to him. “My dad was hyped about it,” he said. For good reason. With three sacks last week in Cleveland's 24-19 win in prime time over the Pittsburgh Steelers, Garrett became the seventh player to reach double-digit sacks in seven straight seasons since the stat became official in 1982. The others: Lawrence Taylor (1984-90), Reggie White (1985-93), Bruce Smith (1992-98), John Randle (1992-99), DeMarcus Ware (2006-12) and Jared Allen (2007-13). All of them is in the Hall of Fame except for Allen. “Hall of Famer,” Garrett said in praising the retired Minnesota Vikings edge rusher, who is again on the doorstep of induction as a semifinalist for the fifth straight year. Garrett is on track to get his own bronze bust one day in Canton, but until then, he's humbled to be in such elite company. “Guys I looked up to when I started my journey into this game,” said Garrett, who tries to bolster his resume on Monday night when the Browns (3-8) visit the Denver Broncos (7-5). “It’s absolutely amazing to be amongst those guys, not just looking up at them but looking side to side and standing amongst them. "So I want to continue to find myself on those lists and hopefully stand alone at the end of the day.” He's on his way. The NFL's reigning Defensive Player of the Year is having another monster season but probably not getting the recognition he deserves as the Browns, upended by continuous quarterback issues, have fallen way short of expectations. Garrett used the national TV platform against the Steelers to remind any detractors of his greatness. He sacked Russell Wilson three times, forced a fumble and outplayed Pittsburgh's T.J. Watt, the player to whom he is most often compared. The Garrett vs. Watt debate went to another level in February. On the day Garrett received his DPOY award, second-place finisher Watt seemed to take a shot at the Browns star by posting “Nothing I'm not used to” on social media. Those comments stuck with Garrett, who following the win over Pittsburgh — and Watt being held without a sack — didn't hold back in declaring himself the league's best pass rusher. “I wanted to make it known that I’m the guy, I’m the No. 1 edge defender,” Garrett said. It was an unusual boast from Garrett, who was asked why he felt he needed to express himself. “Because part of my journey of being the best player that I can be is I think I can be the best player that there is currently,” he said. ”So I have to live up to those expectations I have for myself. That’s just on the road to be the player that I want to be.” Garrett's unrelenting drive is what sets him apart. Although he'll enter Monday's game with 98 1/2 sacks and can become just the fifth player to reach 100 in his first eight seasons, joining White, Ware, Allen and Watt, it's not enough. “I still took too long,” said Garrett, who can become the first to do it before turning 29. “It’d have been tough to catch Mr. White, but hopefully this next however many number will come quicker than the first 100. So we’ll go out there and we’ll do what I do and try to take it up a notch.” Browns defensive coordinator Jim Schwartz marvels at Garrett's output despite double- and triple-team blocking. “He just continues to do stuff,” Schwartz said. “His production is so high, even though he’s a marked man, even though every game plan starts with, ‘Don’t let 95 wreck the game,’ and he still finds a way to wreck games.” Schwartz doesn't need to see any lists to know Garrett belongs among the best to ever rush a quarterback. “Yes, he does,” Schwartz said. "I think he’s just starting to hit his prime. I think he still has a lot left in front of him. The sky is the limit as far as he goes. And when it’s all said and done, maybe you’re comparing other people to him. That should probably be a goal for him.” AP NFL: https://apnews.com/hub/nflThis photo taken on Dec. 3, 2024 shows the plenary session of the 2024 World Conference on Traditional Medicine in Beijing, capital of China. The conference kicked off Tuesday in Beijing under the theme “Diversity, Inheritance and Innovation: Traditional Medicine for All.” — Xinhua photo BEIJING (Dec 8): Alex Jacobs, who attended the 2024 World Conference on Traditional Medicine that concluded in Beijing this week, was thrilled to experience a blend of traditional Chinese medicine (TCM) moxibustion and Qigong in the exhibition area between sessions. He Nian, a moxibustionist from the Beijing Zhiai Academy of Chinese Traditional Medicine, skillfully stimulated acupoints on Jacobs’ back with her fingers to promote blood flow, winning the admiration of visitors, especially foreign guests. He then placed a small, gently heated moxibustion pot, shaped like the Temple of Heaven — one of Beijing’s iconic architectural landmarks — on Jacobs’ left palm while flexing his right shoulder and arm. “Very comfortable and relaxing,” Jacobs exclaimed. “She has a lot of strength in her hands, which was very impressive.” Another highlight in the exhibition area was an intelligent moxibustion robot featuring four types of moxibustion treatment. Operators could customize settings, including acupoints, techniques, duration, amplitude and speed, through its advanced control panel. “This product not only saves labor and enhances the accuracy of moxibustion treatment but also ensures a smoke-free and pollution-free moxibustion process,” said Li Lin, chairman of a biotechnology company based in northwest China’s Shaanxi Province, the developer of the intelligent moxibustion robot. According to Li, in just one morning, foreign guests from countries including the United States, Switzerland, Belarus, Hungary and Kazakhstan visited the company’s exhibition booth to learn more about the products. “Among them, guests from Egypt and the Republic of Korea expressed interest in purchasing the product, with the Egyptian guest even inquiring about the freight cost for the equipment, priced at 300,000 yuan (about 41,755 U.S. dollars),” Li said. Scenes like these at the event reflect the growing global recognition of TCM for its unique strengths in disease prevention, control and rehabilitation. Data shows that TCM has spread to 196 countries and regions, with more than one-third of the world’s population having received TCM treatment. Over the years, the Chinese government has worked closely with the World Health Organization (WHO) to integrate traditional medicines more deeply into the global health system. China has signed TCM cooperation agreements with over 40 governments, regional authorities and international organizations. A total of 30 high-quality overseas TCM centers have been established in countries participating in the Belt and Road Initiative. Meanwhile, the WHO has included traditional medicine, with TCM as the mainstay, in the 11th revision of the International Classification of Diseases. Traditional medicine plays an important role in helping achieve universal health coverage, and TCM has much experience for the world to draw from, said Martin Taylor, the WHO representative in China. “Chinese medicine is incredibly popular in the West,” said Jacobs, who is a TCM doctor and was appointed as the CEO of the British Acupuncture Council six months ago. “In the UK, everyone has either had acupuncture before or knows someone who has had it.” About 20 years ago, Jacobs, an enthusiast of Chinese culture, traveled to Taiwan to study Chinese language. Unexpectedly, he developed a deep passion for TCM. Upon returning to his home country, Jacobs, who already held a bachelor’s degree in economics, spent another five years studying acupuncture, massage and TCM at university. According to Jacobs, the council has more than 3,000 members, all of whom undergo at least three years of training in TCM, and is committed to helping the public find qualified practitioners. In Hungary, the first EU country to legislate on TCM, the public has a relatively higher acceptance of TCM. According to the Hungarian Central Statistical Office, 25 percent of the Hungarian population is familiar with and has received TCM treatments. TCM products can be found in nearly 5,000 mainstream pharmacies across Central and Eastern Europe, said Chen Zhen, president of the Association of Chinese Medicine Academies of Central and Eastern Europe. “More than 5,000 Western acupuncturists trained in the past 30 years have become the main force in promoting TCM in the region,” Chen said. China plans to train over 1,300 individuals from abroad in TCM over the next three years, the National Administration of Traditional Chinese Medicine announced Wednesday at the conference’s closing ceremony. The initiative aims to promote international exchanges and enhance the expertise of professionals in the field. “Chinese medicine is an advanced technology,” Jacobs said. “However, the vast majority of the wisdom and knowledge of TCM has not yet made an impact. It has the potential to revolutionize healthcare.” — Xinhua
None49ers QB Brock Purdy, DE Nick Bosa out, Brandon Allen to start at Green BayLiverpool shines in Champions League, dumping Real Madrid down the table. Dortmund rises to 4th
None
MC elections to follow 2023’s ward delimitation amid row
Autry scores 16 as George Washington downs Illinois State 72-64
Hensley 6-9 0-0 14, Massey 1-2 1-2 3, Davis 6-13 2-2 15, Dibba 5-9 1-1 11, Mayo 2-5 0-0 6, Steffe 1-6 0-0 3, Sykes 4-7 2-3 10, Sharp 5-6 2-2 12, Moreno 3-4 1-1 7. Totals 33-61 9-11 81. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.NEW YORK (AP) — New York City Mayor Eric Adams appears open to switching parties to become a Republican, as he declined to rule out a future change in political allegiances during a pair of interviews Friday that came as he has increasing warmed to President-elect Donald Trump. The comments from Adams, the top Democrat in one of the country's most liberal cities, riled critics who have grown concerned over the mayor's increasing willingness to throw his support behind Trump and his hardline immigration policies. Adams, who faces federal corruption charges , was a registered Republican in the 1990s and early 2000s but has spent his political career as a Democrat. In a Friday morning interview with the local cable news station NY1, Adams was asked if he would consider a return to the GOP. The Democrat appeared to leave open the possibility of a switch. “The party that’s the most important for me is the American party,” he said. “I’m a part of the American party. I love this country. This is the home of the free, the land of the brave.” In another interview about a half-hour later on PIX11, Adams said he would run for reelection as a Democrat but still appeared to leave some wiggle room for his future. “So no matter what party I’m on or vote on, I’m going to push for the American values," he said. "And I think America has told us, stop the squabbling, leaders, and start leading us out of the crisis that we’re facing.” Adams won office on a centrist platform and has spent significant time as mayor quarreling with the progressive wing of his party. But his rhetoric has taken a noticeable rightward turn in the weeks since Trump's election victory, particularly on immigration, with Adams boosting the president-elect's platform and appearing enthusiastic about the incoming administration. Rather than restricting cooperation with Immigration and Customs Enforcement, as he once promised, Adams recently expressed a willingness to roll back the city’s so-called sanctuary policies, and he plans to meet with Trump’s top border official over concerns about what the mayor said was the “rising illegal alien crime rate in New York City.” He has also praised those in Trump’s orbit, including Elon Musk, who has claimed falsely that Democrats are illegally “importing” migrants to garner votes. “This is a racehorse that wanted to run its right pace and we’ve been holding back that racehorse out of fear of being canceled,” Adams said of the country Tuesday. “And now you have a bunch of people who are not afraid of being canceled.” The shift comes as Adams is trying to fight off an indictment on federal corruption charges while governing the city and gearing up to run for a second term. Adams has pleaded not guilty in his criminal case, in which he has been accused of accepting free or discounted overseas trips and illegal campaign contributions from people looking to gain his influence, including people connected to Turkey or the Turkish government. Adams’ critics have seized on his recent comments about the Trump administration as a move toward self-preservation, accusing the mayor of cozying up to the next president in an effort to secure a pardon in his corruption case. “Eric Adams continues to sound more like he is auditioning for a job in right-wing media than running for reelection in a Democratic primary,” said Zohran Mamdani, a state assembly member who is challenging against Adams in the mayoral primary. “Eric Adams is in City Hall because Democratic voters sent him there. To serve his own narrow self-interests, he is clearly prepared to betray them.” Zellnor Myrie, a state senator who is also challenging Adams in the primary, said “at a time when the Republican Party has never been more out of line with New York values, we need a mayor who isn’t scared to call himself a Democrat.” “Instead of playing footsie with the next president, we need a mayor with the courage to stand up for our city,” Myrie wrote on X. Adams on Friday did distance himself from the Trump administration's potential plans to carry out mass deportations, saying, “You know, I’m not for mass deportation, but I’m not for mass saturation.” Still, the mayor's recent remarks are a major departure from his stance before he took office. In June of 2021, a few weeks before winning the Democratic mayoral primary, Adams spoke to a room full of immigrant New Yorkers about the challenges facing city residents who are in the country illegally. “Too many of our neighbors live in the shadows,” he said at the time, “scarred by the abusive rhetoric and tactics of the Trump era and fearing a denial of their rights.” ___ Izaguirre reported from Albany. Anthony Izaguirre And Jake Offenhartz, The Associated PressRich get richer: The $164 trillion inheritance windfall
Political pundits have already called the flatline of Pete Hegseth's nomination to lead the Department of Defense, but he's still lingering around Washington. Speaking to MSNBC on Friday, Matthew Dowd, a former strategist for George W. Bush's presidential campaign, made it clear that Trump has strong opinions about alcoholism and those with drinking problems. "Donald Trump is exceedingly smart at politics, and Donald Trump — and it's been reported in other places — that he was taken aback because they asked him and Pete Hegseth a series of questions, and Pete Hegseth never copped to any of this stuff and never told them," said Dowd. ALSO READ: 'It's offensive': Multiple senators object to Trump's plan to usher in Pete Hegseth "I think Donald Trump doesn't want to be embarrassed," he continued. "As the Reverend said, it's all about performance. I think that this — for Pete Hegseth, he is Bruce Willis in the 'Sixth Sense.' He is dead, and he doesn't know it yet, and the senators hope he passes away without him having to pronounce it." Still, the Fox News weekend co-host pledges to soldier on. Earlier this week it was leaked that Trump was talking to Gov. Ron DeSantis (R-FL) as a possible replacement for Hegseth. So, while Trump is saying on Truth Social he continues to stand behind Hegseth, he's also attending the Army-Navy game with DeSantis, who was in the Navy. Hegseth was in the Army, though it is unclear if he was invited. Marc Caputo wrote for The Bulwark that the Trump team has appreciated that Hegseth has helped take the spotlight off other controversial figures like Robert F. Kennedy Jr. and Tulsi Gabbard. "Hegseth is a heatshield," a senior Trump adviser told the Bulwark. "Pete can take the heat, and that’s better for everyone else." See the video below or at the link here. - YouTube youtu.be
RGC Resources, Inc. Raises Annual Dividend to $0.83 per ShareNone
TikTok's future in the U.S. appeared uncertain on Friday after a federal appeals court rejected a legal challenge to a law that requires the social media platform to cut ties with its China-based parent company or be banned by mid-January. A panel of three judges on The U.S. Court of Appeals for the District of Columbia Circuit ruled unanimously that the law withstood constitutional scrutiny, rebuffing arguments from the two companies that the statute violated their rights and the rights of TikTok users in the U.S. The government has said it wants ByteDance, TikTok's parent company, to divest its stakes. But if it doesn't and the platform goes away, it would have a seismic impact on the lives of content creators who rely on the platform for income as well as users who use it for entertainment and connection. Here are some details on the ruling and what could happen next: In their lawsuit, TikTok and ByteDance, which is also a plaintiff in the case, had challenged the law on various fronts, arguing in part that the statute ran afoul of the First Amendment and was an unconstitutional bill of attainder that unfairly targeted the two companies. But the court sided with attorneys for the Justice Department who said that the government was attempting to address national security concerns and the way in which it chose to do so did not violate the constitution. The Justice Department has argued in court that TikTok poses a national security risk due to its connections to China. Officials say that Chinese authorities can compel ByteDance to hand over information on TikTok's U.S. patrons or use the platform to spread, or suppress, information. However, the U.S. hasn't publicly provided examples of that happening. The appeals court ruling, written by Judge Douglas Ginsburg, said the law was “carefully crafted to deal only with control by a foreign adversary." The judges also rejected the claim that the statute was an unlawful bill of attainder or a taking of property in violation of the Fifth Amendment. Furthermore, Ginsburg wrote the law did not violate the First Amendment because the government is not looking to “suppress content or require a certain mix of content” on TikTok. TikTok and ByteDance are expected to appeal the case to the Supreme Court, but it's unclear whether the court will take up the case. TikTok indicated in a statement on Friday the two companies are preparing to take their case to high court, saying the Supreme Court has “an established historical record of protecting Americans’ right to free speech." "We expect they will do just that on this important constitutional issue,” a company spokesperson said. Alan Morrison, a professor at The George Washington University Law School, said he expects the Supreme Court to take up the case because of the novelty of the issues raised in the lawsuit. If that happens, attorneys for the two companies still have to convince the court to grant them an emergency stay that will prevent the government from enforcing the Jan. 19 divestiture deadline stipulated in the law, Morrison said. Such a move could drag out the process until the Justices make a ruling. Tiffany Cianci, a TikTok content creator who has supported the platform, said she was not shocked about the outcome of the court's ruling on Friday because lower courts typically defer to the executive branch on these types of cases. She believes the company will have a stronger case at the Supreme Court. “I believe that the next stages are more likely to produce a victory for TikTokers and for TikTok as a whole,” Cianci said. Another wild card is President-elect Donald Trump, who tried to ban TikTok during his first term but said during the recent presidential campaign that he is now against such action . The Trump transition team has not offered details on how Trump plans to carry out his pledge to “save TikTok." But spokeswoman Karoline Leavitt said in a statement last month that he plans to “deliver” on his campaign promises. After Trump takes office on Jan. 20th, it would fall on his Justice Department to enforce the law and punish any potential violators. Penalties would apply to any app stores that would violate a prohibition on TikTok and to internet hosting services which would be barred from supporting it. Some have speculated that Trump could ask his Justice Department to abstain from enforcing the law. But tech companies like Apple and Google, which offer TikTok's app on their app stores, would then have to trust that the administration would not come after them for any violations. Craig Singleton, senior director of the China program at the Foundation for Defense of Democracies, said enforcement discretion — or executive orders — can not override existing law, leaving Trump with “limited room for unilateral action." There are other things Trump could potentially do. It's possible he could invoke provisions of the law that allow the president to determine whether a sale or a similar transaction frees TikTok from “foreign adversary” control. Another option is to urge Congress to repeal the law. But that too would require support from congressional Republicans who have overwhelmingly supported the prospect of getting TikTok out of the hands of a Chinese company. In a statement issued Friday, Republican Rep. John Moolenaar of Michigan, chairman of the House Select Committee on China, said he was “optimistic that President Trump will facilitate an American takeover of TikTok” and allow its continued use in the United States. ByteDance has said it won't sell TikTok . And even if it wanted to, a sale of the proprietary algorithm that powers TikTok is likely to get blocked under Chinese export controls that the country issued in 2020. That means if TikTok is sold without the algorithm, its likely that the buyer would only purchase a shell of the platform that doesn't contain the technology that made the app a cultural powerhouse. Still, some investors, including Trump’s former Treasury Secretary Steven Mnuchin and billionaire Frank McCourt, have expressed interest in buying it. This week, a spokesperson for McCourt’s Project Liberty initiative, which aims to protect online privacy, said participants in their bid have made informal commitments of more than $20 billion in capital. The spokesperson did not disclose the identity of the participants.
After drubbing, San Jose Sharks look for response in South Florida